Check out the Detailed Program! Learn More

Updates on Endoscopic Treatment of Achalasia

Achalasia is a rare esophageal motility disorder in which the lower esophageal sphincter fails to relax and normal peristalsis is lost. Patients may experience progressive dysphagia, regurgitation, chest discomfort, weight loss, or difficulty managing both liquids and solid foods. Because the underlying nerve and muscle damage cannot currently be reversed, treatment focuses on reducing outflow resistance.

Endoscopic therapy has reshaped the clinical conversation. Pneumatic dilation remains an established option, while peroral endoscopic myotomy (POEM) has expanded the ability to tailor treatment to disease subtype, symptom pattern, and anatomy. These approaches are central to modern discussions of durable symptom relief and careful post-treatment surveillance.

The 17th World Congress for Esophageal Diseases brought specialists together to discuss research, procedural innovation, and practical patient care. Educational materials connected with the meeting, including registration details, help clinicians explore sessions addressing achalasia, therapeutic endoscopy, and evolving standards of care.

Why Achalasia Treatment Is Changing

Traditional management aimed to disrupt the lower esophageal sphincter with pneumatic dilation, laparoscopic Heller myotomy, or botulinum toxin injection. Each approach can relieve obstruction, yet outcomes vary according to age, manometric subtype, esophageal dilation, prior procedures, and the experience of the treating team.

High-resolution manometry has made it easier to classify achalasia into types I, II, and III. Type III, or spastic achalasia, often requires a longer myotomy because abnormal contractions may extend farther up the esophageal body. Endoscopic therapy allows physicians to adjust the length and direction of the muscular incision with considerable precision.

Peroral Endoscopic Myotomy In Focus

POEM is performed by creating a small mucosal entry point, developing a submucosal tunnel, and dividing the circular muscle fibers at the gastroesophageal junction. The mucosal entry is then closed with clips. This approach avoids external incisions and can provide a long myotomy for patients with spastic disease.

A major development has been the shift toward individualized myotomy length. A short procedure may be sufficient for classic achalasia, while a longer proximal myotomy can address type III disease or prominent spasm. The choice should be guided by symptoms, manometry, timed barium esophagram, endoscopic findings, and the operator’s assessment.

Matching Procedures To Patients

POEM is highly effective for many patients, but it is not automatically the best option for everyone. Pneumatic dilation may be attractive for selected individuals who prefer a less invasive staged treatment, particularly when the anatomy and disease pattern suggest a favorable response. Botulinum toxin is generally reserved for people who are poor candidates for more definitive therapy because its benefit often fades.

Prior treatment also matters. POEM can be used after unsuccessful dilation or surgical myotomy in selected cases, although scar tissue and altered anatomy may increase technical complexity. Evaluation at a specialist center can help balance expected symptom improvement against procedural risk and long-term reflux concerns.

Treatment approach Typical role Important strengths Key considerations
POEM Definitive endoscopic muscle division Tailored myotomy; useful for spastic disease Reflux monitoring and treatment may be needed
Pneumatic dilation Established nonsurgical disruption of the sphincter Familiar technique; may be repeated Perforation risk and possible need for retreatment
Botulinum toxin Frail or high-risk patients Low procedural burden Relief is often temporary
Heller myotomy Surgical definitive therapy Durable option with fundoplication available Requires surgery and postoperative recovery

Measuring Success Beyond Dysphagia Relief

Clinical success should be assessed with more than a patient’s first report of improved swallowing. Eckardt symptom scores, timed barium studies, endoscopy, and manometry can help identify persistent obstruction, ineffective clearance, or recurrent disease. A patient may feel better while still retaining significant esophageal stasis, so objective follow-up has an important role.

Gastroesophageal reflux is one of the principal trade-offs after myotomy. Acid exposure can occur without classic heartburn, making post-procedure symptoms easy to underestimate. Depending on the patient’s symptoms and risk profile, clinicians may use acid suppression, endoscopy, pH monitoring, or other testing to guide ongoing care.

Managing Technical And Long-Term Risks

Potential complications of endoscopic treatment include mucosal injury, bleeding, infection, capnoperitoneum, mediastinal emphysema, and incomplete myotomy. Careful closure of the mucosotomy, perioperative imaging when indicated, and structured observation protocols have improved safety. Experience with advanced endoscopy remains an important factor in reducing avoidable complications.

Long-standing achalasia can cause progressive esophageal dilation, tortuosity, inflammation, and nutritional problems. Advanced disease may respond less predictably than earlier disease, and end-stage megaesophagus can require a different management strategy. Regular clinical review helps detect recurrent obstruction, reflux-related injury, and nutritional decline.

Practical Recommendations For Clinical Learning

The most useful updates are those that connect procedural technique with patient selection and follow-up. Congress presentations and research abstracts can place POEM within the broader field of esophageal disorders rather than treating it as an isolated technical procedure.

Clinicians reviewing contemporary approaches should focus on:

  • Using high-resolution manometry to identify the achalasia subtype before treatment.
  • Considering symptom severity, esophageal morphology, prior interventions, and surgical risk together.
  • Discussing POEM, pneumatic dilation, and surgical myotomy as individualized options.
  • Planning reflux assessment and symptom surveillance after any effective sphincter-disrupting therapy.
  • Referring complex or recurrent cases to a multidisciplinary esophageal center.

Continuing Education In Esophageal Care

Endoscopic treatment continues to evolve through refinements in myotomy length, procedural imaging, reflux prevention, and long-term outcome measurement. The most reliable care combines technical expertise with a clear understanding of disease biology and the patient’s goals.

Review the ISDE 2021 educational resources to revisit specialist perspectives on achalasia, therapeutic endoscopy, and esophageal disease research. Engaging with the congress material can support more informed discussions about selecting, performing, and following up modern endoscopic treatments.

About ISDE

The ISDE is an international, multispecialty society devoted to the study of the esophagus in disease and in health that was founded in 1979. The aims of the ISDE are to promote the exchange of scientific and medical knowledge among specialists in the field, to maintain interchange with organizations and industries, and to encourage basic and clinical research in fields related to the esophagus. In order to promote the professional and educational development of individuals interested in the esophagus, the ISDE sponsors its own journal, international congresses, and other educational programs. The ISDE Secretariat was in Tokyo, Japan, from 1979 to 2004, and then resided in Los Angeles, California, from 2004 through 2010. Since 2010 the Secretariat has been in Vancouver, British Columbia, under the auspices of International Conferences Service, Ltd. The ISDE welcomes participation by existing members and encourages individuals who are professionally interested in the esophagus to become members. Benefits include reduced registration fees at our congresses and other educational offerings, restricted access to website content and member search capability, access to webcasts, reduced subscription rates for our journal, and the opportunity to help lead this organization into a position of leadership in the worldwide medical community.